Evidence map›Paper›PMID 41489326›Full record

ArticleAIDS (London, England)2026

Could a macular telangiectasia type 2-like phenotype characterize retinal JC virus infection?

Fanny Varenne, Aurore Siegfried-Vergnon, Sébastien Lhomme, Emmanuel Treiner, Béatrice Pignolet, Marine Joly, Fabrice Bonneville, Peggy Gandia, Christophe Rodriguez, Irene Cortese and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fanny VarenneDepartment of Ophthalmology.
Aurore Siegfried-VergnonDepartment of Pathology.
Sébastien LhommeDepartment of Virology, Toulouse University Hospital.
Emmanuel TreinerToulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 - CNRS UMR5051 - Toulouse III University.
Béatrice PignoletToulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 - CNRS UMR5051 - Toulouse III University.
Marine JolyDepartment of Infectious and Tropical Diseases.
Fabrice BonnevilleDepartment of Neuroradiology.
Peggy GandiaNEO-I3D Research Group.
Christophe RodriguezDepartment of Microbiology, GenoBioMICs Platform, Institut Mondor de Recherche Biomédicale, Henri Mondor Hospital, AP-HP, Université Paris-Est.
Irene CorteseExperimental Immunotherapeutics Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Guillaume Martin-BlondelToulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 - CNRS UMR5051 - Toulouse III University.
Vincent SolerDepartment of Ophthalmology.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41489326
PMCPMC12700697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.